Literature DB >> 12217669

Aggressive surgical treatment of elderly patients following subarachnoid haemorrhage: management outcome results.

John D Laidlaw1, Kevin H Siu.   

Abstract

This report presents 74 consecutive cases of subarachnoid haemorrhage (SAH) in patients aged 70 years or older, compared with the 317 consecutive younger patients treated during the same period. An ultra-early surgical strategy for all SAH cases was used throughout the study period. Management outcome for all grades of elderly patients was independent in 38%, dependent in 14% and death in 49%. Surgical 3-month outcome of good grade elderly patients was independent 53%, dependent 19% and death 28%; and for poor grades was independent 35%, dependent 15% and death 50%. Elderly poor grade patients had similar outcome to younger patients, although good grade patients had better outcome in the younger group than the elderly group. Despite ultra-early surgery, rebleeding (<12 h of SAH) occurred in 9% of the elderly series. Aggressive, ultra-early treatment is likely to benefit elderly SAH patients, the potential benefit being greater for poor grade elderly patients. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12217669     DOI: 10.1054/jocn.2002.1097

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Subarachnoid haemorrhage in patients > or = 75 years: clinical course, treatment and outcome.

Authors:  D J Nieuwkamp; G J E Rinkel; R Silva; P Greebe; D A Schokking; J M Ferro
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

2.  Endovascular management for intracranial ruptured aneurysms in elderly patients: outcome and technical aspects.

Authors:  F Mont'alverne; M Musacchio; V Tolentino; C Riquelme; A Tournade
Journal:  Neuroradiology       Date:  2005-05-11       Impact factor: 2.804

3.  Treatment and outcome of aneurysmal subarachnoid haemorrhage in the elderly patient.

Authors:  Veit Braun; Stefan Rath; Gregor Antoniadis; Hans-Peter Richter; Wolfgang Börm
Journal:  Neuroradiology       Date:  2005-03-15       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.